Global and United States Central Nervous System Therapy Market Report & Forecast 2022-2028

• Description
• Table of Contents
• Table of Figures
• PDF Download

• Description
• Table of Contents
• Table of Figures
• PDF Download

Market Analysis and Insights: Global and United States Central Nervous System Therapy Market
This report focuses on global and United States Central Nervous System Therapy market, also covers the segmentation data of other regions in regional level and county level.

Due to the COVID-19 pandemic, the global Central Nervous System Therapy market size is estimated to be worth US$  million in 2022 and is forecast to a readjusted size of US$  million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, Antidepressant Treatment accounting for % of the Central Nervous System Therapy global market in 2021, is projected to value US$  million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Hospital was the leading segment, accounting for over  percent market share in 2021, and altered to an  % CAGR throughout this forecast period.

In United States the Central Nervous System Therapy market size is expected to grow from US$  million in 2021 to US$  million by 2028, at a CAGR of % during the forecast period  2022-2028.

Global Central Nervous System Therapy Scope and Market Size
Central Nervous System Therapy market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Central Nervous System Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Central Nervous System Therapy market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type
    Antidepressant Treatment
    Antipsychotic Therapy
    Other CNS Disorder

Segment by Application
    Hospital
    Clinic

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        China Taiwan
        Indonesia
        Thailand
        Malaysia
    Latin America
        Mexico
        Brazil
        Argentina
        Colombia
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

By Company
    Abbvie
    Alkermes
    Allergan
    AstraZeneca
    BIAL
    Bristol-myers Squibb
    Eisai
    Endo Pharmaceuticals
    Eli Lilly and Company
    Hoffmann-LA Roche

 1 Study Coverage
    1.1 Central Nervous System Therapy Product Introduction
    1.2 Global Central Nervous System Therapy Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Central Nervous System Therapy Sales in US$ Million for the Year 2017-2028
        1.2.2 Global Central Nervous System Therapy Sales in Volume for the Year 2017-2028
    1.3 United States Central Nervous System Therapy Outlook 2017 VS 2022 VS 2028
        1.3.1 United States Central Nervous System Therapy Sales in US$ Million for the Year 2017-2028
        1.3.2 United States Central Nervous System Therapy Sales in Volume for the Year 2017-2028
    1.4 Central Nervous System Therapy Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.4.1 The Market Share of United States Central Nervous System Therapy in Global, 2017 VS 2022 VS 2028
        1.4.2 The Growth Rate of Central Nervous System Therapy Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.5 Central Nervous System Therapy Market Dynamics
        1.5.1 Central Nervous System Therapy Industry Trends
        1.5.2 Central Nervous System Therapy Market Drivers
        1.5.3 Central Nervous System Therapy Market Challenges
        1.5.4 Central Nervous System Therapy Market Restraints
    1.6 Study Objectives
    1.7 Years Considered

 2 Market by Type
    2.1 Central Nervous System Therapy Market Segment by Type
        2.1.1 Antidepressant Treatment
        2.1.2 Antipsychotic Therapy
        2.1.3 Other CNS Disorder
    2.2 Global Central Nervous System Therapy Market Size by Type
        2.2.1 Global Central Nervous System Therapy Sales in Value, by Type (2017, 2022 & 2028)
        2.2.2 Global Central Nervous System Therapy Sales in Volume, by Type (2017, 2022 & 2028)
        2.2.3 Global Central Nervous System Therapy Average Selling Price (ASP) by Type (2017, 2022 & 2028)
    2.3 United States Central Nervous System Therapy Market Size by Type
        2.3.1 United States Central Nervous System Therapy Sales in Value, by Type (2017, 2022 & 2028)
        2.3.2 United States Central Nervous System Therapy Sales in Volume, by Type (2017, 2022 & 2028)
        2.3.3 United States Central Nervous System Therapy Average Selling Price (ASP) by Type (2017, 2022 & 2028)

 3 Market by Application
    3.1 Central Nervous System Therapy Market Segment by Application
        3.1.1 Hospital
        3.1.2 Clinic
    3.2 Global Central Nervous System Therapy Market Size by Application
        3.2.1 Global Central Nervous System Therapy Sales in Value, by Application (2017, 2022 & 2028)
        3.2.2 Global Central Nervous System Therapy Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 Global Central Nervous System Therapy Average Selling Price (ASP) by Application (2017, 2022 & 2028)
    3.3 United States Central Nervous System Therapy Market Size by Application
        3.3.1 United States Central Nervous System Therapy Sales in Value, by Application (2017, 2022 & 2028)
        3.3.2 United States Central Nervous System Therapy Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 United States Central Nervous System Therapy Average Selling Price (ASP) by Application (2017, 2022 & 2028)

 4 Global Central Nervous System Therapy Competitor Landscape by Company
    4.1 Global Central Nervous System Therapy Market Size by Company
        4.1.1 Top Global Central Nervous System Therapy Manufacturers Ranked by Revenue (2021)
        4.1.2 Global Central Nervous System Therapy Revenue by Manufacturer (2017-2022)
        4.1.3 Global Central Nervous System Therapy Sales by Manufacturer (2017-2022)
        4.1.4 Global Central Nervous System Therapy Price by Manufacturer (2017-2022)
    4.2 Global Central Nervous System Therapy Concentration Ratio (CR)
        4.2.1 Central Nervous System Therapy Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Central Nervous System Therapy in 2021
        4.2.3 Global Central Nervous System Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Central Nervous System Therapy Manufacturing Base Distribution, Product Type
        4.3.1 Global Central Nervous System Therapy Manufacturers, Headquarters and Distribution of Producing Region
        4.3.2 Manufacturers Central Nervous System Therapy Product Type
        4.3.3 Date of International Manufacturers Enter into Central Nervous System Therapy Market
    4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
    4.5 United States Central Nervous System Therapy Market Size by Company
        4.5.1 Top Central Nervous System Therapy Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Central Nervous System Therapy Revenue by Players (2020, 2021 & 2022)
        4.5.3 United States Central Nervous System Therapy Sales by Players (2020, 2021 & 2022)

 5 Global Central Nervous System Therapy Market Size by Region
    5.1 Global Central Nervous System Therapy Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Central Nervous System Therapy Market Size in Volume by Region (2017-2028)
        5.2.1 Global Central Nervous System Therapy Sales in Volume by Region: 2017-2022
        5.2.2 Global Central Nervous System Therapy Sales in Volume Forecast by Region (2023-2028)
    5.3 Global Central Nervous System Therapy Market Size in Value by Region (2017-2028)
        5.3.1 Global Central Nervous System Therapy Sales in Value by Region: 2017-2022
        5.3.2 Global Central Nervous System Therapy Sales in Value by Region: 2023-2028

 6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Central Nervous System Therapy Market Size YoY Growth 2017-2028
        6.1.2 North America Central Nervous System Therapy Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 United States
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Central Nervous System Therapy Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Central Nervous System Therapy Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 China Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
    6.3 Europe
        6.3.1 Europe Central Nervous System Therapy Market Size YoY Growth 2017-2028
        6.3.2 Europe Central Nervous System Therapy Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Central Nervous System Therapy Market Size YoY Growth 2017-2028
        6.4.2 Latin America Central Nervous System Therapy Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
        6.4.6 Colombia
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Central Nervous System Therapy Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Central Nervous System Therapy Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 UAE

 7 Company Profiles
    7.1 Abbvie
        7.1.1 Abbvie Corporation Information
        7.1.2 Abbvie Description and Business Overview
        7.1.3 Abbvie Central Nervous System Therapy Sales, Revenue and Gross Margin (2017-2022)
        7.1.4 Abbvie Central Nervous System Therapy Products Offered
        7.1.5 Abbvie Recent Development
    7.2 Alkermes
        7.2.1 Alkermes Corporation Information
        7.2.2 Alkermes Description and Business Overview
        7.2.3 Alkermes Central Nervous System Therapy Sales, Revenue and Gross Margin (2017-2022)
        7.2.4 Alkermes Central Nervous System Therapy Products Offered
        7.2.5 Alkermes Recent Development
    7.3 Allergan
        7.3.1 Allergan Corporation Information
        7.3.2 Allergan Description and Business Overview
        7.3.3 Allergan Central Nervous System Therapy Sales, Revenue and Gross Margin (2017-2022)
        7.3.4 Allergan Central Nervous System Therapy Products Offered
        7.3.5 Allergan Recent Development
    7.4 AstraZeneca
        7.4.1 AstraZeneca Corporation Information
        7.4.2 AstraZeneca Description and Business Overview
        7.4.3 AstraZeneca Central Nervous System Therapy Sales, Revenue and Gross Margin (2017-2022)
        7.4.4 AstraZeneca Central Nervous System Therapy Products Offered
        7.4.5 AstraZeneca Recent Development
    7.5 BIAL
        7.5.1 BIAL Corporation Information
        7.5.2 BIAL Description and Business Overview
        7.5.3 BIAL Central Nervous System Therapy Sales, Revenue and Gross Margin (2017-2022)
        7.5.4 BIAL Central Nervous System Therapy Products Offered
        7.5.5 BIAL Recent Development
    7.6 Bristol-myers Squibb
        7.6.1 Bristol-myers Squibb Corporation Information
        7.6.2 Bristol-myers Squibb Description and Business Overview
        7.6.3 Bristol-myers Squibb Central Nervous System Therapy Sales, Revenue and Gross Margin (2017-2022)
        7.6.4 Bristol-myers Squibb Central Nervous System Therapy Products Offered
        7.6.5 Bristol-myers Squibb Recent Development
    7.7 Eisai
        7.7.1 Eisai Corporation Information
        7.7.2 Eisai Description and Business Overview
        7.7.3 Eisai Central Nervous System Therapy Sales, Revenue and Gross Margin (2017-2022)
        7.7.4 Eisai Central Nervous System Therapy Products Offered
        7.7.5 Eisai Recent Development
    7.8 Endo Pharmaceuticals
        7.8.1 Endo Pharmaceuticals Corporation Information
        7.8.2 Endo Pharmaceuticals Description and Business Overview
        7.8.3 Endo Pharmaceuticals Central Nervous System Therapy Sales, Revenue and Gross Margin (2017-2022)
        7.8.4 Endo Pharmaceuticals Central Nervous System Therapy Products Offered
        7.8.5 Endo Pharmaceuticals Recent Development
    7.9 Eli Lilly and Company
        7.9.1 Eli Lilly and Company Corporation Information
        7.9.2 Eli Lilly and Company Description and Business Overview
        7.9.3 Eli Lilly and Company Central Nervous System Therapy Sales, Revenue and Gross Margin (2017-2022)
        7.9.4 Eli Lilly and Company Central Nervous System Therapy Products Offered
        7.9.5 Eli Lilly and Company Recent Development
    7.10 Hoffmann-LA Roche
        7.10.1 Hoffmann-LA Roche Corporation Information
        7.10.2 Hoffmann-LA Roche Description and Business Overview
        7.10.3 Hoffmann-LA Roche Central Nervous System Therapy Sales, Revenue and Gross Margin (2017-2022)
        7.10.4 Hoffmann-LA Roche Central Nervous System Therapy Products Offered
        7.10.5 Hoffmann-LA Roche Recent Development

 8 Industry Chain and Sales Channels Analysis
    8.1 Central Nervous System Therapy Industry Chain Analysis
    8.2 Central Nervous System Therapy Key Raw Materials
        8.2.1 Key Raw Materials
        8.2.2 Central Nervous System Therapy Distributors
    8.3 Central Nervous System Therapy Production Mode & Process
    8.4 Central Nervous System Therapy Sales and Marketing
        8.4.1 Central Nervous System Therapy Sales Channels
        8.4.2 Central Nervous System Therapy Distributors
    8.5 Central Nervous System Therapy Customers

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

List of Tables
    Table 1. Central Nervous System Therapy CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Central Nervous System Therapy Market Trends
    Table 3. Central Nervous System Therapy Market Drivers
    Table 4. Central Nervous System Therapy Market Challenges
    Table 5. Central Nervous System Therapy Market Restraints
    Table 6. Global Central Nervous System Therapy Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Central Nervous System Therapy Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Central Nervous System Therapy Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Central Nervous System Therapy Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Central Nervous System Therapy Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Central Nervous System Therapy Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Central Nervous System Therapy Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Central Nervous System Therapy Sales by Manufacturer, (K Units), 2017-2022
    Table 14. Global Central Nervous System Therapy Sales Share by Manufacturer, 2017-2022
    Table 15. Global Central Nervous System Therapy Price by Manufacturer (2017-2022) & (US$/Unit)
    Table 16. Global Central Nervous System Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Central Nervous System Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Central Nervous System Therapy as of 2021)
    Table 18. Top Players of Central Nervous System Therapy in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Central Nervous System Therapy Product Type
    Table 20. Date of International Manufacturers Enter into Central Nervous System Therapy Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Central Nervous System Therapy Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Central Nervous System Therapy Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Central Nervous System Therapy Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Central Nervous System Therapy Sales by Players, (K Units), 2020, 2021 & 2022
    Table 26. United States Central Nervous System Therapy Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Central Nervous System Therapy Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Central Nervous System Therapy Sales in Volume by Region (2017-2022) & (K Units)
    Table 29. Global Central Nervous System Therapy Sales in Volume Forecast by Region (2023-2028) & (K Units)
    Table 30. Global Central Nervous System Therapy Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Central Nervous System Therapy Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Central Nervous System Therapy Sales in Volume by Country (2017-2028) & (K Units)
    Table 33. North America Central Nervous System Therapy Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Central Nervous System Therapy Sales in Volume by Region (2017-2028) & (K Units)
    Table 35. Asia Pacific Central Nervous System Therapy Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Central Nervous System Therapy Sales in Volume by Country (2017-2028) & (K Units)
    Table 37. Europe Central Nervous System Therapy Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Central Nervous System Therapy Sales in Volume by Country (2017-2028) & (K Units)
    Table 39. Latin Americaa Central Nervous System Therapy Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Central Nervous System Therapy Sales in Volume by Country (2017-2028) & (K Units)
    Table 41. Middle East and Africa Central Nervous System Therapy Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Abbvie Corporation Information
    Table 43. Abbvie Description and Business Overview
    Table 44. Abbvie Central Nervous System Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 45. Abbvie Central Nervous System Therapy Product
    Table 46. Abbvie Recent Development
    Table 47. Alkermes Corporation Information
    Table 48. Alkermes Description and Business Overview
    Table 49. Alkermes Central Nervous System Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 50. Alkermes Product
    Table 51. Alkermes Recent Development
    Table 52. Allergan Corporation Information
    Table 53. Allergan Description and Business Overview
    Table 54. Allergan Central Nervous System Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 55. Allergan Product
    Table 56. Allergan Recent Development
    Table 57. AstraZeneca Corporation Information
    Table 58. AstraZeneca Description and Business Overview
    Table 59. AstraZeneca Central Nervous System Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 60. AstraZeneca Product
    Table 61. AstraZeneca Recent Development
    Table 62. BIAL Corporation Information
    Table 63. BIAL Description and Business Overview
    Table 64. BIAL Central Nervous System Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 65. BIAL Product
    Table 66. BIAL Recent Development
    Table 67. Bristol-myers Squibb Corporation Information
    Table 68. Bristol-myers Squibb Description and Business Overview
    Table 69. Bristol-myers Squibb Central Nervous System Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 70. Bristol-myers Squibb Product
    Table 71. Bristol-myers Squibb Recent Development
    Table 72. Eisai Corporation Information
    Table 73. Eisai Description and Business Overview
    Table 74. Eisai Central Nervous System Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 75. Eisai Product
    Table 76. Eisai Recent Development
    Table 77. Endo Pharmaceuticals Corporation Information
    Table 78. Endo Pharmaceuticals Description and Business Overview
    Table 79. Endo Pharmaceuticals Central Nervous System Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 80. Endo Pharmaceuticals Product
    Table 81. Endo Pharmaceuticals Recent Development
    Table 82. Eli Lilly and Company Corporation Information
    Table 83. Eli Lilly and Company Description and Business Overview
    Table 84. Eli Lilly and Company Central Nervous System Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 85. Eli Lilly and Company Product
    Table 86. Eli Lilly and Company Recent Development
    Table 87. Hoffmann-LA Roche Corporation Information
    Table 88. Hoffmann-LA Roche Description and Business Overview
    Table 89. Hoffmann-LA Roche Central Nervous System Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 90. Hoffmann-LA Roche Product
    Table 91. Hoffmann-LA Roche Recent Development
    Table 92. Key Raw Materials Lists
    Table 93. Raw Materials Key Suppliers Lists
    Table 94. Central Nervous System Therapy Customers List
    Table 95. Central Nervous System Therapy Distributors List
    Table 96. Research Programs/Design for This Report
    Table 97. Key Data Information from Secondary Sources
    Table 98. Key Data Information from Primary Sources
List of Figures
    Figure 1. Central Nervous System Therapy Product Picture
    Figure 2. Global Central Nervous System Therapy Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Central Nervous System Therapy Market Size 2017-2028 (US$ Million)
    Figure 4. Global Central Nervous System Therapy Sales 2017-2028 (K Units)
    Figure 5. United States Central Nervous System Therapy Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Central Nervous System Therapy Market Size 2017-2028 (US$ Million)
    Figure 7. United States Central Nervous System Therapy Sales 2017-2028 (K Units)
    Figure 8. United States Central Nervous System Therapy Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Central Nervous System Therapy Market Share in Global, in Volume (K Units) 2017-2028
    Figure 10. Central Nervous System Therapy Report Years Considered
    Figure 11. Product Picture of Antidepressant Treatment
    Figure 12. Product Picture of Antipsychotic Therapy
    Figure 13. Product Picture of Other CNS Disorder
    Figure 14. Global Central Nervous System Therapy Market Share by Type in 2022 & 2028
    Figure 15. Global Central Nervous System Therapy Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 16. Global Central Nervous System Therapy Sales Market Share in Value by Type (2017-2028)
    Figure 17. Global Central Nervous System Therapy Sales by Type (2017-2028) & (K Units)
    Figure 18. Global Central Nervous System Therapy Sales Market Share in Volume by Type (2017-2028)
    Figure 19. Global Central Nervous System Therapy Price by Type (2017-2028) & (US$/Unit)
    Figure 20. United States Central Nervous System Therapy Market Share by Type in 2022 & 2028
    Figure 21. United States Central Nervous System Therapy Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 22. United States Central Nervous System Therapy Sales Market Share in Value by Type (2017-2028)
    Figure 23. United States Central Nervous System Therapy Sales by Type (2017-2028) & (K Units)
    Figure 24. United States Central Nervous System Therapy Sales Market Share in Volume by Type (2017-2028)
    Figure 25. United States Central Nervous System Therapy Price by Type (2017-2028) & (US$/Unit)
    Figure 26. Product Picture of Hospital
    Figure 27. Product Picture of Clinic
    Figure 28. Global Central Nervous System Therapy Market Share by Application in 2022 & 2028
    Figure 29. Global Central Nervous System Therapy Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 30. Global Central Nervous System Therapy Sales Market Share in Value by Application (2017-2028)
    Figure 31. Global Central Nervous System Therapy Sales by Application (2017-2028) & (K Units)
    Figure 32. Global Central Nervous System Therapy Sales Market Share in Volume by Application (2017-2028)
    Figure 33. Global Central Nervous System Therapy Price by Application (2017-2028) & (US$/Unit)
    Figure 34. United States Central Nervous System Therapy Market Share by Application in 2022 & 2028
    Figure 35. United States Central Nervous System Therapy Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 36. United States Central Nervous System Therapy Sales Market Share in Value by Application (2017-2028)
    Figure 37. United States Central Nervous System Therapy Sales by Application (2017-2028) & (K Units)
    Figure 38. United States Central Nervous System Therapy Sales Market Share in Volume by Application (2017-2028)
    Figure 39. United States Central Nervous System Therapy Price by Application (2017-2028) & (US$/Unit)
    Figure 40. North America Central Nervous System Therapy Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 41. North America Central Nervous System Therapy Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 42. United States Central Nervous System Therapy Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Canada Central Nervous System Therapy Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Europe Central Nervous System Therapy Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 45. Europe Central Nervous System Therapy Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 46. Germany Central Nervous System Therapy Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 47. France Central Nervous System Therapy Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. U.K. Central Nervous System Therapy Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Italy Central Nervous System Therapy Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Russia Central Nervous System Therapy Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Asia-Pacific Central Nervous System Therapy Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 52. Asia-Pacific Central Nervous System Therapy Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 53. China Central Nervous System Therapy Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Japan Central Nervous System Therapy Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. South Korea Central Nervous System Therapy Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. India Central Nervous System Therapy Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Australia Central Nervous System Therapy Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. China Taiwan Central Nervous System Therapy Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Indonesia Central Nervous System Therapy Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Thailand Central Nervous System Therapy Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Malaysia Central Nervous System Therapy Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Latin America Central Nervous System Therapy Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 63. Latin America Central Nervous System Therapy Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 64. Mexico Central Nervous System Therapy Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Brazil Central Nervous System Therapy Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Argentina Central Nervous System Therapy Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Colombia Central Nervous System Therapy Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Middle East & Africa Central Nervous System Therapy Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 69. Middle East & Africa Central Nervous System Therapy Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 70. Turkey Central Nervous System Therapy Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. Saudi Arabia Central Nervous System Therapy Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. UAE Central Nervous System Therapy Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. Central Nervous System Therapy Value Chain
    Figure 74. Central Nervous System Therapy Production Process
    Figure 75. Channels of Distribution
    Figure 76. Distributors Profiles
    Figure 77. Bottom-up and Top-down Approaches for This Report
    Figure 78. Data Triangulation
    Figure 79. Key Executives Interviewed

Market Analysis and Insights: Global and United States Central Nervous System Therapy Market
This report focuses on global and United States Central Nervous System Therapy market, also covers the segmentation data of other regions in regional level and county level.

Due to the COVID-19 pandemic, the global Central Nervous System Therapy market size is estimated to be worth US$  million in 2022 and is forecast to a readjusted size of US$  million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, Antidepressant Treatment accounting for % of the Central Nervous System Therapy global market in 2021, is projected to value US$  million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Hospital was the leading segment, accounting for over  percent market share in 2021, and altered to an  % CAGR throughout this forecast period.

In United States the Central Nervous System Therapy market size is expected to grow from US$  million in 2021 to US$  million by 2028, at a CAGR of % during the forecast period  2022-2028.

Global Central Nervous System Therapy Scope and Market Size
Central Nervous System Therapy market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Central Nervous System Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Central Nervous System Therapy market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type
    Antidepressant Treatment
    Antipsychotic Therapy
    Other CNS Disorder

Segment by Application
    Hospital
    Clinic

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        China Taiwan
        Indonesia
        Thailand
        Malaysia
    Latin America
        Mexico
        Brazil
        Argentina
        Colombia
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

By Company
    Abbvie
    Alkermes
    Allergan
    AstraZeneca
    BIAL
    Bristol-myers Squibb
    Eisai
    Endo Pharmaceuticals
    Eli Lilly and Company
    Hoffmann-LA Roche